Eric Lefkofsky Using Tempus in the Drive to Cure Cancer

Eric Lefkofsky is a 47 year old billionaire, according to Forbes magazine. He is an entrepreneur who has started many highly successful businesses. For example, he is co-founder and chairman of both Tempus and Groupon. In addition, he launched Echo Global Logistics, InnerWorkings, Mediaocean, and Uptake. This graduate of the the University of Michigan, both undergraduate and law school, has been the driving force behind businesses that have dramatically changed the world.

One area that Lefkofsky has emphasized in both his business dealings and his charity work is the cure for cancer. He and his wife Liz have donated millions of dollars through their Lefkofsky Family Foundation to the research and cure of cancer. Specifically, they donated $1 million to the Robert H. Lurie Comprehensive Cancer Center at Northwestern University. Other donations include $1.2 million to his alma mater, the University of Michigan, for cancer research, money for gastric cancer research at Stanford University, and funds for breast cancer research at New York’s Weill Cornell Medicine.

So it is only natural that Lefkofsky would take his talents and put them to use with a company that uses technology and data to solve cancer. Tempus is a company that he started for the sole purpose of assisting in the cure for cancer. This is an area where he believes that modern technology, specifically data, has not been properly utilized. The idea behind Tempus is use data about a specific patient to provide an individualized treatment plan. Information produced at the molecular level can provide invaluable information that can make a cure for cancer a reality.

The first area that Tempus uses is sequencing, which involves genomes that allow a physician to understand the specifics of a patient’s tumor. The second area is analytics which is a process where the proprietary algorithms assess and compare the cancer in one person with other data bases to more fully understand the nature of the illness which leads to more specific and focused treatment. Validation comes next, as Tempus strives to make sure everything it develops can be proved. In other words, they want to make sure what they have found is true and will work for each patient. The final area is reporting. Tempus sends a detailed report to the physician based upon the results in the prior three areas. That report is data driven and details the proposed treatment and learn more about Eric Lefkofsky.

Eric Lefkofsky is dedicated to bringing cancer treatment up to the same level as technology in other areas of life. He sees Tempus as the vehicle to do just that and more information click here.

More Visit: http://chicagoinno.streetwise.co/2016/07/22/eric-lefkofskys-next-move-curing-cancer-at-tempus/